Literature DB >> 18755103

[Non-alcoholic hepatic steatosis. An update].

Llorenç Caballería Rovira1, Pere Torán Montserrat, María Antonia Auladell Llorens, Guillem Pera Blanco.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18755103      PMCID： PMC7713407          DOI： 10.1157/13125408

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  35 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

Review 2.  [Non-alcoholic steatohepatitis].

Authors:  Juan Caballería; Juan Rodés
Journal:  Med Clin (Barc)       Date:  2003-05-10       Impact factor: 1.725

Review 3.  Statins and hepatotoxicity: focus on patients with fatty liver.

Authors:  Naga Chalasani
Journal:  Hepatology       Date:  2005-04       Impact factor: 17.425

4.  The evolution of severe steatosis after bariatric surgery is related to insulin resistance.

Authors:  Philippe Mathurin; Florent Gonzalez; Olivier Kerdraon; Emmanuelle Leteurtre; Laurent Arnalsteen; Antoine Hollebecque; Alexandre Louvet; Sébastien Dharancy; Perrine Cocq; Thomas Jany; Jeanne Boitard; Pierre Deltenre; Monique Romon; François Pattou
Journal:  Gastroenterology       Date:  2006-05       Impact factor: 22.682

5.  Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Hiroshi Sakugawa; Tomofumi Nakayoshi; Kasen Kobashigawa; Tsuyoshi Yamashiro; Tatsuji Maeshiro; Satoru Miyagi; Joji Shiroma; Akiyo Toyama; Tomokuni Nakayoshi; Fukunori Kinjo; Atsushi Saito
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

6.  Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.

Authors:  Marianne Ziol; Adriana Handra-Luca; Adrien Kettaneh; Christos Christidis; Frédéric Mal; Farhad Kazemi; Victor de Lédinghen; Patrick Marcellin; Daniel Dhumeaux; Jean-Claude Trinchet; Michel Beaugrand
Journal:  Hepatology       Date:  2005-01       Impact factor: 17.425

7.  The effects of sibutramine and orlistat on the ultrasonographic findings, insulin resistance and liver enzyme levels in obese patients with non-alcoholic steatohepatitis.

Authors:  Tevfik Sabuncu; Yasar Nazligul; Mustafa Karaoglanoglu; Edip Ucar; Feryal Birden Kilic
Journal:  Rom J Gastroenterol       Date:  2003-09

8.  A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis.

Authors:  Kittichai Promrat; Glen Lutchman; Gabriel I Uwaifo; Renee J Freedman; Alejandro Soza; Theo Heller; Edward Doo; Marc Ghany; Ahalya Premkumar; Yoon Park; T Jake Liang; Jack A Yanovski; David E Kleiner; Jay H Hoofnagle
Journal:  Hepatology       Date:  2004-01       Impact factor: 17.425

9.  Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

Authors:  J Ludwig; T R Viggiano; D B McGill; B J Oh
Journal:  Mayo Clin Proc       Date:  1980-07       Impact factor: 7.616

10.  Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study.

Authors:  S Bellentani; C Tiribelli; G Saccoccio; M Sodde; N Fratti; C De Martin; G Cristianini
Journal:  Hepatology       Date:  1994-12       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.